| IL-4 and IL-13 signaling in allergic airway disease N Gour, M Wills-Karp Cytokine 75 (1), 68-78, 2015 | 516 | 2015 |
| A mast-cell-specific receptor mediates neurogenic inflammation and pain DP Green, N Limjunyawong, N Gour, P Pundir, X Dong Neuron 101 (3), 412-420. e3, 2019 | 285 | 2019 |
| NRF2 activation promotes aggressive lung cancer and associates with poor clinical outcomes A Singh, A Daemen, D Nickles, SM Jeon, O Foreman, K Sudini, F Gnad, ... Clinical Cancer Research 27 (3), 877-888, 2021 | 106 | 2021 |
| Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity U Smole, N Gour, J Phelan, G Hofer, C Köhler, B Kratzer, PA Tauber, ... Nature immunology 21 (7), 756-765, 2020 | 82 | 2020 |
| Dysregulated invertebrate tropomyosin–dectin-1 interaction confers susceptibility to allergic diseases N Gour, S Lajoie, U Smole, M White, D Hu, P Goddard, S Huntsman, ... Science immunology 3 (20), eaam9841, 2018 | 63 | 2018 |
| C3a is required for ILC2 function in allergic airway inflammation N Gour, U Smole, HM Yong, IP Lewkowich, N Yao, A Singh, E Gabrielson, ... Mucosal immunology 11 (6), 1653-1662, 2018 | 40 | 2018 |
| Unique pulmonary immunotoxicological effects of urban PM are not recapitulated solely by carbon black, diesel exhaust or coal fly ash N Gour, K Sudini, SM Khalil, AM Rule, P Lees, E Gabrielson, ... Environmental research 161, 304-313, 2018 | 29 | 2018 |
| Epithelial cell regulation of allergic diseases N Gour, S Lajoie Current allergy and asthma reports 16, 1-9, 2016 | 20 | 2016 |
| Distinct roles of cytolytic effector molecules for antigen‐restricted killing by CTL in vivo EM Janssen, EE Lemmens, N Gour, RA Reboulet, DR Green, ... Immunology and cell biology 88 (7), 761-765, 2010 | 17 | 2010 |
| Interleukin 13 (IL‐13) alters hypoxia‐associated genes and upregulates CD73 SM Khalil, I Bernstein, H Kulaga, N Gour, N Rowan, S Lajoie, AP Lane International Forum of Allergy & Rhinology 10 (9), 1096-1102, 2020 | 12 | 2020 |
| Eradication of Staphylococcus aureus Biofilm Infection by Persister Drug Combination R Yee, Y Yuan, A Tarff, C Brayton, N Gour, J Feng, Y Zhang Antibiotics 11 (10), 1278, 2022 | 11 | 2022 |
| Identification of persister drug combination clinafloxacin+ cefuroxime+ gentamicin that eradicates persistent Pseudomonas aeruginosa infection in a murine cystic fibrosis model Y Yuan, R Yee, N Gour, X Dong, J Feng, W Shi, Y Zhang Infectious Microbes & Diseases 5 (1), 21-28, 2023 | 6 | 2023 |
| Epigenetic regulation of epithelial dectin‐1 through an IL‐33‐STAT3 axis in allergic disease HM Yong, N Gour, D Sharma, SM Khalil, AP Lane, S Lajoie Allergy 77 (1), 207-217, 2022 | 6 | 2022 |
| A GPCR-neuropeptide axis dampens hyperactive neutrophils by promoting an alternative-like polarization during bacterial infection N Gour, HM Yong, A Magesh, A Atakkatan, F Andrade, S Lajoie, X Dong Immunity 57 (2), 333-348. e6, 2024 | 3 | 2024 |
| The MRGPR family of receptors in immunity N Gour, X Dong Immunity 57 (1), 28-39, 2024 | 2 | 2024 |
| Ranking of Major Classes of Antibiotics for Activity against Stationary Phase Pseudomonas aeruginosa and Identification of Clinafloxacin + Cefuroxime + Gentamicin Drug … Y Yuan, R Yee, N Gour, X Dong, J Feng, W Shi, Y Zhang bioRxiv, 686105, 2019 | 2 | 2019 |
| Air Pollution Drives Macrophage Senescence through a Phagolysosome–15-Lipoxygenase Pathway SA Thomas, HM Yong, AM Rule, N Gour, S Lajoie ImmunoHorizons 8 (4), 307-316, 2024 | 1 | 2024 |
| Suppression of type-2 mediated allergic diseases by dectin-1 N Gour, S Lajoie, M Wills-Karp The Journal of Immunology 198 (1_Supplement), 194.1-194.1, 2017 | 1 | 2017 |
| Identification and function of a C3 hiIL-33+ fibroblast population in the lungs A Atakkatan, N Gour, A Magesh, HM Yong, S Lajoie The Journal of Immunology 210 (1_Supplement), 176.09-176.09, 2023 | | 2023 |
| Primary lung fibroblasts respond to IL-33, IL-13, and IL-17A by secreting factors that activate macrophages J Venezia, N Gour, J Loube, W Mitzner, AL Scott bioRxiv, 2023.02. 28.530495, 2023 | | 2023 |
